RACHEL DONAHUE: Open Payments
NPI 1851059026 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$109 in 4 payments from 3 companies in 2025. Trend: 2023 $339 · 2024 $410 · 2025 $109
Food & beverage: $109
| Company | Payments | Amount |
|---|---|---|
| TerSera Therapeutics LLC | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: Xermelo, FRUZAQLA, KEYTRUDA, Zoladex.
Industry payments across MD — which companies pay providers there.
